In diffuse-type tenosynovial giant-cell tumor showing overexpression of CSF1R, after treatment with CSF1R-blocking agents, patients experienced relevant clinical regressions (57, 58). The gene discussed is CSF1R; the disease is tenosynovial giant cell tumor, diffuse type.